These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5402966)

  • 1. [Hemodynamics and principles of therapy of patients with obliterative atherosclerosis].
    Zavgorodniĭ LG; Taranenko LD
    Klin Khir (1962); 1969 Sep; 9():51-5. PubMed ID: 5402966
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of myocalm on the hemodynamics of peripheral and kidney circulation in subjects with healthy blood vessels and in patients with obliterative arterial vascular diseases].
    Hackel F
    Z Gesamte Inn Med; 1966 Jul; 21(14):435-9. PubMed ID: 5992292
    [No Abstract]   [Full Text] [Related]  

  • 3. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
    Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN
    Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of central and peripheral hemodynamics in obliterative vascular diseases of the extremities].
    Davydova LI
    Klin Khir (1962); 1978 Jul; (7):50-2. PubMed ID: 682454
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of pathogenetic treatment of arterial obliterative diseases of the extremities].
    Belokurov IuN; Rudnev NE
    Khirurgiia (Mosk); 1993 Feb; (2):15-8. PubMed ID: 8084143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
    Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
    Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arteriosclerosis obliterans and ozone therapy. Its administration by different routes].
    Romero Valdés A; Blanco González R; Menéndez Cepero S; Gómez Moraleda M; Ley Pozo J
    Angiologia; 1993; 45(5):177-9. PubMed ID: 8285365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of peripheral opiate receptor agonist dalargin on exercise tolerance in patients with coronary and peripheral arteries atherosclerosis].
    Maslov LN; Fedorova NA; Dudko VA; Karpov RS
    Fiziol Cheloveka; 2002; 28(5):81-7. PubMed ID: 12397935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional potentials of the microcirculatory system in patients with thrombo-obliterative arterial diseases of the lower extremities].
    Karpik AI; Polynskiĭ AA
    Vestn Khir Im I I Grek; 1985 Apr; 134(4):57-61. PubMed ID: 4013019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of eicosapentaenoic acid for diabetic patients with arteriosclerosis obliterans.
    Okuda Y; Mizutami M; Tanaka K; Isaka M; Yamashita K
    Diabetes Res Clin Pract; 1992 Nov; 18(2):139-40. PubMed ID: 1478154
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human chorionic gonadotropin in the treatment of chronic peripheral obliterative arteriosclerotic arteriopathies of the lower limbs].
    Bagliani A; Moia R
    Minerva Med; 1978 Apr; 69(19):1287-93. PubMed ID: 662155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional state of regional hemodynamics in patients with diabetes mellitus and arteriosclerosis obliterans of the lower extremities].
    Zubkova ST
    Klin Khir (1962); 1987; (7):19-21. PubMed ID: 3656952
    [No Abstract]   [Full Text] [Related]  

  • 13. [Peripheral hemodynamics in patients with arteriosclerosis obliterans and arteritis studied by ultrasonic dopplerography].
    Koshkin VM; Zaĭtseva LA; Maliutina IG; Nochevnikov VL
    Vestn Khir Im I I Grek; 1988 Mar; 140(3):89-90. PubMed ID: 3043887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ultrasonic evaluation of regional hemodynamics in arteriosclerosis obliterans of the iliac and femoral arteries].
    Sukharev II; Zhane AK
    Khirurgiia (Mosk); 1990 May; (5):82-5. PubMed ID: 2202874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidant and metabolic therapy of lower limb chronic obliterative arterial disease].
    Koshkin VM; Murav'ev SV; Dadova LV; Kalashov PB
    Angiol Sosud Khir; 2006; 12(3):29-32. PubMed ID: 17641611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical aspects of using Vazaprostan in patients with atherosclerotic involvement of the vessels of the extremities].
    Krotovskiĭ GS; Zabel'skaia TF; Mamedov DM
    Ter Arkh; 1991; 63(8):64-8. PubMed ID: 1792622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative efferent therapy of patients with atherosclerosis obliterans of the lower limbs].
    Neĭmark MI; Elizar'ev AIu; Khorev NG
    Anesteziol Reanimatol; 1997; (2):58-61. PubMed ID: 9221693
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ozone therapy in the advanced stages of arteriosclerosis obliterans].
    Romero Valdés A; Menéndez Cepero S; Gómez Moraleda M; Ley Pozo J
    Angiologia; 1993; 45(4):146-8. PubMed ID: 8239044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K; Sakuma M; Tanabe T
    Arzneimittelforschung; 1985; 35(7A):1198-200. PubMed ID: 4074434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the phase structure of the left ventricle systole in patients with obliterative atherosclerosis of the lower extremities after treatment with naphthalane baths].
    Gulieva SA; Guseĭnov TG
    Vrach Delo; 1991 Jun; (6):94-7. PubMed ID: 1891869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.